Balance Sheet
Accounts PayablesAccumulated ExpensesAssetsCapital LeasesCash & Current InvestmentsCash & EquivalentsCommon EquityCurrent AssetsCurrent LeasesLiabilities and Shareholders EquityNon-Current AssetsNon-Current Deffered RevenueOperating LeasesOther Non-Current AssetsOther Non-Current LiabilitiesPayablesPrepaid AssetsProperty, Plant & Equipment (Net)Retained EarningsShareholder's EquityShort term DebtTotal Current LiabilitiesTotal DebtTotal LiabilitiesTotal Non-Current Liabilities
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Others
Ratios

Dare Bioscience (DARE) Notes Payables (2016 - 2020)

Dare Bioscience (DARE) has disclosed Notes Payables for 4 consecutive years, with $367285.0 as the latest value for Q4 2020.

  • For the quarter ending Q4 2020, Notes Payables changed N/A year-over-year to $367285.0, compared with a TTM value of $367285.0 through Dec 2020, changed N/A, and an annual FY2020 reading of $367285.0, changed N/A over the prior year.
  • Notes Payables was $367285.0 for Q4 2020 at Dare Bioscience, roughly flat from $367285.0 in the prior quarter.
  • Across five years, Notes Payables topped out at $697500.0 in Q4 2016 and bottomed at $367285.0 in Q2 2020.